U.S health officials are updating the prescribing labels of long-acting ADHD medications to carry new warnings for children ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...

The GINA 2025 asthma update includes new guidance on T2 biomarkers, asthma in young children, and climate change, as well as ...

These typically identified errors using drug chart/medical record review (21 studies; 42%) or incident reporting (13 studies; 26%). In 20 of the 44 primary studies (45%), factors associated with ...

Cite this: Ophthalmic Medications in Pediatric Patients - Medscape - Mar 01, 2005. Abstract and Introduction Dosage, Absorption, and Administration of Eye Drops in Children ...

Global Phase 3 BRAVE study will evaluate the efficacy and safety of omaveloxolone in children 2 to BRAVE study will explore the potential of omaveloxolone to address the critical unmet need of the ped ...

Purpose: Rates of serious medication errors in three pediatric inpatient units (intensive care, general medical, and general surgical) were measured before and after introduction of unit-based ...

Parents of autistic children in Texas have turned to Dr Mohsin Maqbool, a pediatric neurologist in Plano, who gives 40 ...

Approval of 45mg/0.5mL solution in a single-dose vial for subcutaneous injection expands dosing flexibility for pediatric patients with plaque psoriasis (PsO) or psoriatic arthritis (PsA) under ...

In December 2024, the FDA approved STEQEYMA in 45mg/0.5mL and 90mg/mL solutions in a single-dose prefilled syringe for subcutaneous injection, and 130mg/26mL in a single-dose vial for intravenous ...

Approval of 45mg/0.5mL solution in a single-dose vial for subcutaneous injection expands dosing flexibility for pediatric patients with p Tuesday, 02 January 2024 12:17 GMT عربي ...